A Retrospective, Multicenter, Controlled Clinical Trail: to Evaluate the Clinical Efficiency of Intracranial Aneurysm Assistive Software in the Morphological Measurement

NCT05804474 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-04-07

No results posted yet for this study

Summary

the goal of this clinical trail is to evaluate the clinical efficiency of intracranial aneurysm assistive software in the morphological measurement. The trail is designed as retrospective, multicenter, controlled clinical trail. Collecting probable cases images retrospectively according to inclusion criteria and exclusion criteria strictly. Controlling bias strictly, to make sure the measurement of intracranial aneurysm assistive software is evaluated reliably and precisely. In our trail, six physicions were recruited, containing three neuroradiologists, two radiologists and a residents. Software-assistant planning controls against no software-assisant planning,which aims to evaluate the improvement of morphological measurement efficiency of physicians.

Conditions

  • Intracranial Aneurysm

Interventions

OTHER

Observational study

Observational study

Sponsors & Collaborators

  • Wuxi No. 2 People's Hospital

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Shanxi Provincial People's Hospital

    collaborator OTHER_GOV
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Beijing Friendship Hospital

    collaborator OTHER
  • Guangzhou Red Cross Hospital

    collaborator OTHER
  • Beijing Tiantan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-03-25
Completion
2023-03-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05804474 on ClinicalTrials.gov